Senestech, Inc. (NASDAQ:SNES) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Friday.

According to Zacks, “SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company’s fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. “

Separately, Roth Capital set a $14.00 price objective on shares of Senestech and gave the company a “buy” rating in a research note on Saturday, May 13th.

Shares of Senestech (NASDAQ:SNES) opened at 2.24 on Friday. Senestech has a 52 week low of $2.03 and a 52 week high of $10.69. The firm’s market capitalization is $23.13 million. The firm has a 50-day moving average of $2.81 and a 200 day moving average of $5.98.

Senestech (NASDAQ:SNES) last released its quarterly earnings data on Thursday, August 10th. The company reported ($0.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.28) by $0.07. The business had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $0.10 million. On average, equities analysts predict that Senestech will post ($1.30) earnings per share for the current fiscal year.

WARNING: “Senestech, Inc. (SNES) Upgraded to “Hold” by Zacks Investment Research” was originally posted by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at

In other news, COO Andrew Altman bought 20,000 shares of the stock in a transaction dated Friday, August 18th. The stock was bought at an average price of $2.77 per share, for a total transaction of $55,400.00. Following the completion of the acquisition, the chief operating officer now directly owns 2,600 shares in the company, valued at approximately $7,202. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Julia Ann Williams bought 10,000 shares of the stock in a transaction dated Wednesday, July 26th. The stock was purchased at an average price of $3.21 per share, with a total value of $32,100.00. Following the acquisition, the director now owns 11,950 shares of the company’s stock, valued at $38,359.50. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 54,100 shares of company stock worth $155,730 and sold 23,411 shares worth $92,433. 27.40% of the stock is currently owned by company insiders.

An institutional investor recently raised its position in Senestech stock. Prudential PLC grew its position in Senestech, Inc. (NASDAQ:SNES) by 49.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 447,971 shares of the company’s stock after purchasing an additional 147,971 shares during the period. Prudential PLC owned about 4.39% of Senestech worth $2,661,000 at the end of the most recent reporting period. Institutional investors own 15.34% of the company’s stock.

Senestech Company Profile

SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.

Get a free copy of the Zacks research report on Senestech (SNES)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related companies with's FREE daily email newsletter.